Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, People's Republic of China.
Oncologist. 2019 Jun;24(6):e260-e274. doi: 10.1634/theoncologist.2018-0220. Epub 2018 Nov 23.
Young survivors of gastric cancer (GC) have better prognoses than elderly patients, yet their disease-specific survival (DSS) has received little attention.
Data on young patients (aged ≤40 years) with GC undergoing resections at three Chinese institutions ( = 542) and from the SEER database ( = 533) were retrospectively analyzed. Three-year conditional disease-specific survival (CS3) was assessed. The effects of well-known prognostic factors over time were analyzed by time-dependent Cox regression.
Overall, young Chinese patients with GC had a better 5-year DSS than U.S. patients (62.8% vs. 54.1%; < .05). The disease-specific mortality likelihood of the entire cohort was not constant over time, with most deaths occurring during the first 3 years after surgery but peaking at 1 and 2 years in China and the U.S., respectively. Based on 5-year survivorship, the CS3 rates of both groups were similar (90.9% [U.S.] vs. 91.5% [China]; > .05). Cox regression showed that for Chinese patients, site, size, T stage, and N stage were independent prognostic factors at baseline ( < .05). For U.S. patients, grade, T stage. and N stage significantly affected DSS at baseline ( < .05). In both groups, only T stage continuously affected DSS within 3 years after gastrectomy. However, for both groups, the initial well-known prognostic factors lost prognostic significance after 5 years of survival (all > .05). Although the 5-year DSS rates of young Chinese patients with T3 and T4a disease were significantly better than those of young U.S. patients, in each T stage, the CS3 of both regions trended toward consistency over time.
For young patients with GC, the factors that predict survival at baseline vary over time. Although the initial 5-year DSS is heterogeneous, insight into conditional survival will help clinicians evaluate the long-term prognoses of survivors while ignoring population differences.
With the increasing number of young survivors of gastric cancer (GC), it is essential for clinicians to understand the dynamic prognosis of these patients. Based on large data sets from China and the U.S., this study found that the prognostic factors that predict survival for young patients with GC at baseline vary over time. Although the initial 5-year disease-specific survival is heterogeneous, insight into conditional survival will help clinicians evaluate the long-term prognoses of survivors while ignoring population differences. This knowledge may be more effective in helping young patients with GC to manage future uncertainties, especially when they need to make important life plans.
与老年患者相比,年轻的胃癌(GC)幸存者预后更好,但他们的疾病特异性生存(DSS)却很少受到关注。
对在中国的三个机构(=542 例)和 SEER 数据库(=533 例)进行切除术的年轻患者(年龄≤40 岁)的数据进行回顾性分析。评估了 3 年条件性疾病特异性生存(CS3)。通过时间依赖性 Cox 回归分析了随着时间推移对众所周知的预后因素的影响。
总体而言,年轻的中国 GC 患者的 5 年 DSS 优于美国患者(62.8%比 54.1%;<.05)。整个队列的疾病特异性死亡率随时间的推移并不稳定,大多数死亡发生在手术后的前 3 年内,但在中国和美国分别在第 1 年和第 2 年达到高峰。根据 5 年生存率,两组的 CS3 率相似(90.9%[美国]比 91.5%[中国];>.05)。Cox 回归显示,对于中国患者,部位、大小、T 分期和 N 分期是基线时的独立预后因素(<.05)。对于美国患者,分级、T 分期和 N 分期在基线时显著影响 DSS(<.05)。在两组中,仅 T 分期在胃切除术后 3 年内持续影响 DSS。然而,对于两组,最初的众所周知的预后因素在 5 年生存后失去了预后意义(均>.05)。尽管患有 T3 和 T4a 疾病的年轻中国 GC 患者的 5 年 DSS 率明显优于年轻的美国患者,但在每个 T 分期中,两个地区的 CS3 随着时间的推移趋于一致。
对于 GC 的年轻患者,预测生存的基线因素随时间而变化。尽管初始的 5 年 DSS 存在异质性,但对条件生存的了解将有助于临床医生在忽略人群差异的情况下评估幸存者的长期预后。
随着年轻的胃癌(GC)幸存者人数的增加,临床医生了解这些患者的动态预后至关重要。基于来自中国和美国的大量数据,本研究发现,预测 GC 年轻患者基线生存的预后因素随时间而变化。尽管初始的 5 年疾病特异性生存存在异质性,但对条件生存的了解将有助于临床医生在忽略人群差异的情况下评估幸存者的长期预后。这种知识在帮助年轻的 GC 患者管理未来的不确定性时可能更有效,尤其是当他们需要制定重要的人生计划时。